The immune microenvironment in EGFR- and ERBB2-mutated lung adenocarcinoma
Sign Up to like & getrecommendations! Published in 2021 at "ESMO Open"
DOI: 10.1016/j.esmoop.2021.100253
Abstract: Background Targeted therapies have improved survival and quality of life for patients with non-small-cell lung cancer with actionable driver mutations. However, epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 gene (HER2,… read more here.
Keywords: egfr; egfr erbb2; expression; ex20mut ... See more keywords